SCHEDULE 13G/A: Perceptive Advisors Reduces Anteris Technologies Stake

Perceptive Advisors and affiliates have reduced their beneficial ownership in Anteris Technologies Global Corp. to 4.7% of common stock.

Summary

• Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. (collectively, the "Reporting Persons") beneficially own 1,705,130 shares of Anteris Technologies Global Corp. common stock.
• This represents 4.7% of the issuer's outstanding common stock, based on 36,062,370 shares outstanding as of August 11, 2025.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating a change from a previously reported beneficial ownership position, now falling below the 5% threshold.
• Perceptive Advisors serves as the investment manager to the Master Fund, and Mr. Edelman is the managing member of Perceptive Advisors, leading to shared voting and dispositive power over the shares.

Sentiment

Score: 4

Explanation: The reduction in beneficial ownership by a significant institutional investor below the 5% reporting threshold is generally perceived negatively, suggesting a potential decrease in confidence or a strategic divestment.

Positives

• Perceptive Life Sciences Master Fund, a specialized life sciences investor, continues to hold a significant stake, indicating ongoing interest in Anteris Technologies.

Negatives

• The reduction in beneficial ownership below the 5% threshold suggests a decrease in conviction or a strategic reallocation of capital by a major institutional investor.
• The investor is no longer required to file subsequent amendments unless their stake again crosses the 5% threshold, potentially reducing transparency on future holdings.

Future Outlook

NA

Industry Context

Institutional ownership, especially by specialized funds like Perceptive Life Sciences, is closely watched in the biotech and medical device sectors as it can signal confidence or concerns about a company's pipeline, clinical trials, or market potential. A reduction in stake by such an investor can lead to increased scrutiny from other market participants.

Stakeholder Impact

• Shareholders may interpret the reduction in stake by a major institutional investor as a negative signal, potentially leading to downward pressure on the stock price.
• Management may face questions regarding the reasons for the institutional investor's reduced position and its implications for future capital access or strategic direction.

Key Dates

Recommendation

The reduction of a significant stake by a specialized institutional investor like Perceptive Life Sciences Master Fund, especially below the 5% reporting threshold, often signals a loss of conviction or a strategic exit. This move could precede further selling pressure and indicates that a key institutional holder sees better opportunities elsewhere or has concerns about Anteris Technologies' future prospects. Investors should consider this as a potential negative indicator.

Keywords

Anteris Technologies, Perceptive Advisors, Joseph Edelman, Perceptive Life Sciences Master Fund, beneficial ownership, Schedule 13G, common stock, institutional investor, biotech, medical devices, equity stake